Carrico J, La EM, Talbird SE, et al. Value of the immunization program for children in the 2017 US birth cohort. Pediatrics. 2022;150(3):e2021056007.
Hill HA, Yankey D, Elam-Evans LD, et al. Decline in vaccination coverage by age 24 months and vaccination inequities among children born in 2020 and 2021—National Immunization Survey-Child, United States, 2021–2023. MMWR Morb Mortal Wkly Rep. 2024;73(38):844-853.
Seither R, Yusuf OB, Dramann D, et al. Coverage with selected vaccines and exemption from school vaccine requirements among children in kindergarten – United States, 2022–23 school year. MMWR Morb Mortal Wkly Rep. 2023;72(45):1217-1224.
American Academy of Family Physicians. Immunizations. October 2023. Accessed November 22, 2024. https://www.aafp.org/about/policies/all/immunizations.html
American Academy of Family Physicians. Immunization exemptions. December 2024. Accessed April 1, 2025. https://www.aafp.org/about/policies/all/immunization-exemptions.html
Cooper S, Schmidt BM, Sambala EZ, et al. Factors that influence parents’ and informal caregivers’ views and practices regarding routine childhood vaccination: a qualitative evidence synthesis. Cochrane Database Syst Rev. 2021(10):CD013265.
Paterson P, Meurice F, Stanberry LR, et al. Vaccine hesitancy and healthcare providers. Vaccine. 2016;34(52):6700-6706.
Jacobson Vann JC, Jacobson RM, Coyne-Beasley T, et al. Patient reminder and recall interventions to improve immunization rates. Cochrane Database Syst Rev. 2018(1):CD003941.
Jong KM, Sikora CA, MacDonald SE. Childhood immunization appointment reminders and recalls: strengths, weaknesses and opportunities to increase vaccine coverage. Public Health. 2021;194:170-175.
Bordley WC, Chelminski A, Margolis PA, et al. The effect of audit and feedback on immunization delivery: a systematic review. Am J Prev Med. 2000;18(4):343-350.
Briss PA, Rodewald LE, Hinman AR, et al. Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services. Am J Prev Med. 2000;18(1suppl):97-140.
Shay LA, Baldwin AS, Betts AC, et al. Parent-provider communication of HPV vaccine hesitancy. Pediatrics. 2018;141(6):e20172312.
Cataldi JR, Kerns ME, O’Leary ST. Evidence-based strategies to increase vaccination uptake: a review. Curr Opin Pediatr. 2020;32(1):151-159.
MacDonald NE, Harmon S, Dube E, et al. Mandatory infant & childhood immunization: rationales, issues and knowledge gaps. Vaccine. 2018;36(39):5811-5818.
Public Health Law; Center for State, Tribal, Local, and Territorial Support; Centers for Disease Control and Prevention. State school immunization requirements and vaccine exemption laws. February 2022. Accessed November 22, 2024. https://www.cdc.gov/phlp/docs/school-vaccinations.pdf
Centers for Disease Control and Prevention. Child immunization schedule notes. November 21, 2024. Accessed April 1, 2025. https://www.cdc.gov/vaccines/hcp/imz-schedules/child-adolescent-notes.html?CDC_AAref_Val=https://www.cdc.gov/vaccines/schedules/hcp/imz/child-schedule-notes.html
US Food and Drug Administration. Vaccines licensed for use in the United States. Accessed May 1, 2024. https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states
Centers for Disease Control and Prevention. Child immunization schedule notes. COVID-19 vaccination. November 21, 2024. Accessed January 14, 2025. https://www.cdc.gov/vaccines/hcp/imz-schedules/child-adolescent-notes.html#note-covid-19
Beladiya J, Kumar A, Vasava Y, et al. Safety and efficacy of COVID-19 vaccines: a systematic review and meta-analysis of controlled and randomized clinical trials. Rev Med Virol. 2024;34(1):e2507.
Poukka E, Andersson NW, Thiesson EM, et al. COVID-19 vaccine effectiveness among adolescents. Pediatrics. 2024;153(2):e2023062520.
Zambrano LD, Newhams MM, Simeone RM, et al.; Overcoming COVID-19 Investigators. Durability of original monovalent mRNA vaccine effectiveness against COVID-19 Omicron-associated hospitalization in children and adolescents – United States, 2021–2023. MMWR Morb Mortal Wkly Rep. 2024;73(15):330-338.
Flaxman S, Whittaker C, Semenova E, et al. Assessment of COVID-19 as the underlying cause of death among children and young people aged 0 to 19 years in the US. JAMA Netw Open. 2023;6(1):e2253590.
Razzaghi H, Forrest CB, Hirabayashi K, et al.; RECOVER Consortium. Vaccine effectiveness against long COVID in children. Pediatrics. 2024;153(4):e2023064446.
Sherman AC, Tuan J, Cantos VD, et al. COVID-19 vaccine efficacy in participants with weakened immune systems from 4 randomized controlled trials. Clin Infect Dis. 2024;79(2):364-374.
Centers for Disease Control and Prevention. Vaccination trends. March 21, 2025. Accessed April 1, 2025. https://www.cdc.gov/respiratory-viruses/data/vaccination-trends.html?CDC_AAref_Val=https://www.cdc.gov/respiratory-viruses/data-research/dashboard/vaccination-trends-children.html
Aldridge SJ, Agrawal U, Murphy S, et al. Uptake of COVID-19 vaccinations amongst 3,433,483 children and young people: meta-analysis of UK prospective cohorts. Nat Commun. 2024;15(1):2363.
Watanabe A, Kani R, Iwagami M, et al. Assessment of efficacy and safety of mRNA COVID-19 vaccines in children aged 5 to 11 years: a systematic review and meta-analysis. JAMA Pediatr. 2023;177(4):384-394.
Cortese MM, Taylor AW, Akinbami LJ, et al. Surveillance for multisystem inflammatory syndrome in US children aged 5–11 years who received Pfizer-BioNTech COVID-19 vaccine, November 2021 through March 2022. J Infect Dis. 2023;228(2):143-148.
Costa C, Moniati F. The epidemiology of COVID-19 vaccine-induced myocarditis. Adv Med. 2024;2024:4470326.
McDonald MA, Kafil TS, Khoury M, et al. Myocarditis and pericarditis after mRNA COVID-19 vaccination: 2024 status and management update. Can J Cardiol. 2024;40(9):1536-1540.
Husby A, Gulseth HL, Hovi P, et al. Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries: population based cohort study. BMJ Med. 2023;2(1):e000373.
Uraguchi K, Matsumoto N, Mitsuhashi T, et al. Pediatric otitis media in Japan: a nationwide longitudinal study of the pre- and post-pneumococcal conjugate vaccine eras born in 2001 and 2010. Vaccine. 2024;42(19):4081-4087.
Hsu HE, Shutt KA, Moore MR, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med. 2009;360(3):244-256.
Feikin DR, Karron RA, Saha SK, et al. The full value of immunisation against respiratory syncytial virus for infants younger than 1 year: effects beyond prevention of acute respiratory illness. Lancet Infect Dis. 2024;24(5):e318-e327.
Fleming-Dutra KE, Jones JM, Roper LE, et al. Use of the Pfizer respiratory syncytial virus vaccine during pregnancy for the prevention of respiratory syncytial virus-associated lower respiratory tract disease in infants: recommendations of the Advisory Committee on Immunization Practices – United States, 2023. MMWR Morb Mortal Wkly Rep. 2023;72(41):1115-1122.
Kampmann B, Madhi SA, Munjal I, et al.; MATISSE Study Group. Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants. N Engl J Med. 2023;388(16):1451-1464.
Venkatesan P. Nirsevimab: a promising therapy for RSV. Lancet Microbe. 2022;3(5):e335.
Drysdale SB, Cathie K, Flamein F. Nirsevimab for prevention of hospitalizations due to RSV in infants. N Engl J Med. 2023;389(26):2425-2435.
Ackerman LK, Serrano JL. Update on routine childhood and adolescent immunizations. Am Fam Physician. 2015;92(6):460-468.
Ackerman LK. Update on immunizations in children and adolescents. Am Fam Physician. 2008;77(11):1561-1568.